Abstract: Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric form of thyroid hormone, or an antagonist thereof, to promote or inhibit angiogenesis in the subject. Compositions of the polymeric forms of thyroid hormone, or thyroid hormone analogs, are also disclosed.
Type:
Grant
Filed:
November 25, 2009
Date of Patent:
August 27, 2013
Assignees:
Albany College of Pharmacy and Health Services, Orway Research Institute, Inc.
Inventors:
Shaker A. Mousa, Faith B. Davis, Paul J. Davis